Highnoon Laboratories Limited (PSX: HINOON) has announced that its Board of Directors has given in-principle approval to explore a potential acquisition, according to a filing submitted to the Pakistan Stock Exchange (PSX) on Monday.
The decision was made during a board meeting held on February 2, 2026.
The company said the proposed acquisition is intended to strengthen its strategic position by expanding its business footprint, enhancing its product range, and achieving operational and commercial synergies. These include broader market access and improved distribution efficiency.
Highnoon clarified that the transaction is still at an early evaluation stage and remains subject to due diligence, negotiations, and the signing of final agreements. The deal will also require all necessary corporate and regulatory approvals, along with other standard conditions.
The company added that it will share further updates in line with applicable laws and the PSX Rule Book as the process moves forward.
